+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam

False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam

Clinical Infectious Diseases 38(6): 913-916

At the bone marrow transplantation center of the San Martino Hospital (Genoa), we observed an increase in the rate of patients with positive Platelia Aspergillus (PA; Bio-Rad) test results, from 10% (38 of 386 patients) in the period from January 1999 through January 2003 to 36% (21 of 59 patients) in the period from February 2003 through May 2003.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 004159688

Download citation: RISBibTeXText

PMID: 14999640

DOI: 10.1086/382224

Related references

Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clinical Infectious Diseases 38(6): 917-920, 2004

False positive galactomannan Platelia due to piperacillin-tazobactam. Medecine et Maladies Infectieuses 42(1): 10-14, 2012

Lack of evidence that false-positive Aspergillus galactomannan antigen test results are due to treatment with piperacillin-tazobactam. Clinical Infectious Diseases 39(9): 1401-2; Author Reply 1402-3, 2004

False positivity of the Aspergillus galactomannan Platelia ELISA because of piperacillin/tazobactam treatment: does it represent a clinical problem?. Journal of Antimicrobial ChemoTherapy 62(5): 1109-1112, 2008

False-positive results by the platelia Aspergillus galactomannan antigen test for patients treated with amoxicillin-clavulanate. Clinical and Vaccine Immunology 15(7): 1132-1133, 2008

Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United States. Journal of Clinical Microbiology 52(6): 2199-2201, 2014

Assessing the risk of false positive serum galactomannan among patients receiving piperacillin/tazobactam for febrile neutropenia. Medical Mycology 55(5): 535-540, 2017

Intravenous PLASMA-LYTE as a major cause of false-positive results of platelia Aspergillus test for galactomannan detection in serum. Journal of Clinical Microbiology 45(9): 3141-3142, 2007

False positive galactomannan results in adult hematological patients treated with piperacillin-tazobactam. Revista Iberoamericana de Micologia 24(2): 106-112, 2007

Treatment with piperacillin-tazobactam and Aspergillus galactomannan test results for patients with hematological malignancies. European Journal of Internal Medicine 18(1): 79, 2007

Reactivity of platelia Aspergillus galactomannan antigen with piperacillin-tazobactam: clinical implications based on achievable concentrations in serum. Antimicrobial Agents and ChemoTherapy 48(6): 1989-1992, 2004

Piperacillin/tazobactam (Tazocin™) seems to be no longer responsible for false-positive results of the galactomannan assay. Journal of Antimicrobial ChemoTherapy 67(7): 1746-1748, 2012

False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. New England Journal of Medicine 349(24): 2366-2367, 2003

High incidence of false-positive Aspergillus galactomannan test results in patients with aspiration pneumonia. Journal of the American Geriatrics Society 57(5): 935-936, 2009

Repeating the Platelia™ Aspergillus test in samples positive for serum galactomannan: Is it necessary?. Revista Iberoamericana de Micologia 32(3): 204-207, 2016